BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23073862)

  • 1. Fabry disease: raising awareness of the disease among physicians.
    Carubbi F; Bonilauri L
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S227-31. PubMed ID: 23073862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The neurological manifestations of Fabry disease. A review].
    Firsov KV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease: a review of current management strategies.
    Mehta A; Beck M; Eyskens F; Feliciani C; Kantola I; Ramaswami U; Rolfs A; Rivera A; Waldek S; Germain DP
    QJM; 2010 Sep; 103(9):641-59. PubMed ID: 20660166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease: Review and experience during newborn screening.
    Hsu TR; Niu DM
    Trends Cardiovasc Med; 2018 May; 28(4):274-281. PubMed ID: 29100912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fabry disease : diagnosis and treatment].
    Üçeyler N; Sommer C
    Schmerz; 2012 Sep; 26(5):609-19. PubMed ID: 23052995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and Chronic Kidney Disease in Fabry Disease.
    Tapia D; Kimonis V
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105423. PubMed ID: 33160817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac manifestations of Anderson-Fabry disease and efficacy of enzyme replacement therapy].
    Hagège A
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S238-42. PubMed ID: 21211672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A boy with Fabry disease with the onset at the age of four].
    Liu YP; Huang Y; Wang Q; Wu TF; Ma YY; Li XY; Song JQ; Yang YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):307-11. PubMed ID: 23591357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of Fabry disease among rheumatologists--current status and perspectives.
    Cimaz R; Guillaume S; Hilz MJ; Horneff G; Manger B; Thorne JC; Møller AT; Wulffraat NM; Roth J
    Clin Rheumatol; 2011 Apr; 30(4):467-75. PubMed ID: 20393867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy for Fabry disease: a systematic review of available evidence.
    Schaefer RM; Tylki-Szymańska A; Hilz MJ
    Drugs; 2009 Nov; 69(16):2179-205. PubMed ID: 19852524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
    Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
    Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management and treatment of children with Fabry disease: A United States-based perspective.
    Hopkin RJ; Jefferies JL; Laney DA; Lawson VH; Mauer M; Taylor MR; Wilcox WR;
    Mol Genet Metab; 2016 Feb; 117(2):104-13. PubMed ID: 26546059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease.
    Morel CF; Clarke JT
    Expert Opin Biol Ther; 2009 May; 9(5):631-9. PubMed ID: 19368525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey.
    Morand O; Johnson J; Walter J; Atkinson L; Kline G; Frey A; Politei J; Schiffmann R
    Adv Ther; 2019 Oct; 36(10):2866-2880. PubMed ID: 31435831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.
    Bersano A; Lanfranconi S; Valcarenghi C; Bresolin N; Micieli G; Baron P
    Acta Neurol Scand; 2012 Aug; 126(2):77-97. PubMed ID: 22428782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
    Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
    CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anderson-Fabry disease: developments in diagnosis and treatment.
    Mehta AB
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S66-74. PubMed ID: 20040315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease: a treatable lysosomal storage disorder.
    Phadke SR; Mandal K; Girisha KM
    Natl Med J India; 2009; 22(1):20-2. PubMed ID: 19761154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.